Synopsis
Synopsis
0
VMF
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 136.11 g/mol |
---|---|
Molecular Formula | C5H4N4O |
XLogP3 | -0.5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 0 |
Exact Mass | 136.03851076 g/mol |
Monoisotopic Mass | 136.03851076 g/mol |
Topological Polar Surface Area | 65.8 A^2 |
Heavy Atom Count | 10 |
Formal Charge | 0 |
Complexity | 275 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 10 | |
---|---|
Drug Name | Allopurinol |
PubMed Health | Allopurinol |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | Allopurinol is known chemically as 1,5-Dihydro-4H-pyrazolo[3,4-d ]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Its solubility in water at 37C is 80 mg/dL and is greater in an alkaline solution. Allopurinol Table... |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Watson Labs; Vintage Pharms; Ipca Labs; Mutual Pharm; Apotex; Accord Hlthcare; Sun Pharm Inds; Northstar Hlthcare; Mylan |
2 of 10 | |
---|---|
Drug Name | Allopurinol sodium |
PubMed Health | Allopurinol (Injection) |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | ALOPRIM (allopurinol sodium) for Injection is the brand name for allopurinol, a xanthine oxidase inhibitor. ALOPRIM (allopurinol sodium) for Injection is a sterile solution for intravenous infusion only. It is available in vials as the sterile lyophi... |
Active Ingredient | Allopurinol sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Eurohlth Intl |
3 of 10 | |
---|---|
Drug Name | Aloprim |
PubMed Health | Allopurinol |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | ZYLOPRIM (allopurinol) has the following structural formula:ZYLOPRIM is known chemically as 1,5-dihydro-4H-pyrazolo [3,4-d]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Each scored white tablet contains 100 mg allo... |
Active Ingredient | Allopurinol sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Mylan Institutional |
4 of 10 | |
---|---|
Drug Name | Lopurin |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Dr Reddys La |
5 of 10 | |
---|---|
Drug Name | Zyloprim |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Prometheus Labs |
6 of 10 | |
---|---|
Drug Name | Allopurinol |
PubMed Health | Allopurinol |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | Allopurinol is known chemically as 1,5-Dihydro-4H-pyrazolo[3,4-d ]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Its solubility in water at 37C is 80 mg/dL and is greater in an alkaline solution. Allopurinol Table... |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Watson Labs; Vintage Pharms; Ipca Labs; Mutual Pharm; Apotex; Accord Hlthcare; Sun Pharm Inds; Northstar Hlthcare; Mylan |
7 of 10 | |
---|---|
Drug Name | Allopurinol sodium |
PubMed Health | Allopurinol (Injection) |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | ALOPRIM (allopurinol sodium) for Injection is the brand name for allopurinol, a xanthine oxidase inhibitor. ALOPRIM (allopurinol sodium) for Injection is a sterile solution for intravenous infusion only. It is available in vials as the sterile lyophi... |
Active Ingredient | Allopurinol sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Eurohlth Intl |
8 of 10 | |
---|---|
Drug Name | Aloprim |
PubMed Health | Allopurinol |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | ZYLOPRIM (allopurinol) has the following structural formula:ZYLOPRIM is known chemically as 1,5-dihydro-4H-pyrazolo [3,4-d]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Each scored white tablet contains 100 mg allo... |
Active Ingredient | Allopurinol sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Mylan Institutional |
9 of 10 | |
---|---|
Drug Name | Lopurin |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Dr Reddys La |
10 of 10 | |
---|---|
Drug Name | Zyloprim |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Prometheus Labs |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
10
PharmaCompass offers a list of Allopurinol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Allopurinol manufacturer or Allopurinol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Allopurinol manufacturer or Allopurinol supplier.
PharmaCompass also assists you with knowing the Allopurinol API Price utilized in the formulation of products. Allopurinol API Price is not always fixed or binding as the Allopurinol Price is obtained through a variety of data sources. The Allopurinol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Uriprim manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Uriprim, including repackagers and relabelers. The FDA regulates Uriprim manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Uriprim API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Uriprim manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Uriprim supplier is an individual or a company that provides Uriprim active pharmaceutical ingredient (API) or Uriprim finished formulations upon request. The Uriprim suppliers may include Uriprim API manufacturers, exporters, distributors and traders.
click here to find a list of Uriprim suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Uriprim DMF (Drug Master File) is a document detailing the whole manufacturing process of Uriprim active pharmaceutical ingredient (API) in detail. Different forms of Uriprim DMFs exist exist since differing nations have different regulations, such as Uriprim USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Uriprim DMF submitted to regulatory agencies in the US is known as a USDMF. Uriprim USDMF includes data on Uriprim's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Uriprim USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Uriprim suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Uriprim Drug Master File in Japan (Uriprim JDMF) empowers Uriprim API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Uriprim JDMF during the approval evaluation for pharmaceutical products. At the time of Uriprim JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Uriprim suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Uriprim Drug Master File in Korea (Uriprim KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Uriprim. The MFDS reviews the Uriprim KDMF as part of the drug registration process and uses the information provided in the Uriprim KDMF to evaluate the safety and efficacy of the drug.
After submitting a Uriprim KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Uriprim API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Uriprim suppliers with KDMF on PharmaCompass.
A Uriprim CEP of the European Pharmacopoeia monograph is often referred to as a Uriprim Certificate of Suitability (COS). The purpose of a Uriprim CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Uriprim EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Uriprim to their clients by showing that a Uriprim CEP has been issued for it. The manufacturer submits a Uriprim CEP (COS) as part of the market authorization procedure, and it takes on the role of a Uriprim CEP holder for the record. Additionally, the data presented in the Uriprim CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Uriprim DMF.
A Uriprim CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Uriprim CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Uriprim suppliers with CEP (COS) on PharmaCompass.
A Uriprim written confirmation (Uriprim WC) is an official document issued by a regulatory agency to a Uriprim manufacturer, verifying that the manufacturing facility of a Uriprim active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Uriprim APIs or Uriprim finished pharmaceutical products to another nation, regulatory agencies frequently require a Uriprim WC (written confirmation) as part of the regulatory process.
click here to find a list of Uriprim suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Uriprim as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Uriprim API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Uriprim as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Uriprim and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Uriprim NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Uriprim suppliers with NDC on PharmaCompass.
Uriprim Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Uriprim GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Uriprim GMP manufacturer or Uriprim GMP API supplier for your needs.
A Uriprim CoA (Certificate of Analysis) is a formal document that attests to Uriprim's compliance with Uriprim specifications and serves as a tool for batch-level quality control.
Uriprim CoA mostly includes findings from lab analyses of a specific batch. For each Uriprim CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Uriprim may be tested according to a variety of international standards, such as European Pharmacopoeia (Uriprim EP), Uriprim JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Uriprim USP).